ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag eye disease medicine

Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014 | 2 min read
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Quasi-Lymphatic System in the Rodent Eye Clears Waste
Abby Olena, PhD | Apr 16, 2020 | 3 min read
Two rodent models of glaucoma have defects in the waste drainage system.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Eyes, Nose as Windows to Alzheimer’s
Kerry Grens | Jul 14, 2014 | 2 min read
Failing a sniff test or screening positive on an eye exam may predict people’s chances of developing the neurodegenerative disorder.
FDA Approves Gene Therapy for Spinal Muscular Atrophy
Ashley Yeager | May 27, 2019 | 3 min read
At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.
Geography Helps Epidemiologists To Investigate Spread Of Disease
James Kling | Jul 20, 1997 | 8 min read
'CLEAR AWARENESS': Keith Clark says epidemiologists have recongized the importance of geography in studying infectious diseases. Adventurers of the 18th and 19th centuries in search of gold and new trade routes were not the only ones to value a good map: Early epidemiologists inspected the lay of the land in attempts to discern the causes and spread of diseases. But as unexplored frontiers slowly disappeared, geography came to be taken for granted. In fact, the number of classic epidemiology p
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
diabetes complications type 2 biomarker blood test screen hydroxymethylation epigenetics cytosine
Blood-Based Epigenetic Screen Tests for Diabetes Complications
Katarina Zimmer | Oct 1, 2019 | 4 min read
Researchers could accurately detect life-threatening vascular complications in type 2 diabetes patients by analyzing hydroxymethylated cytosines in freely circulating DNA.
Those We Lost in 2019
Ashley Yeager | Dec 30, 2019 | 6 min read
The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.

Run a Search

ADVERTISEMENT